Combination of pegylated IFN-α2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia

Overview of attention for article published in Blood, June 2011

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (63rd percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

patent: 1 patent

facebook: 1 Facebook page

Citations

dimensions_citation: 173 Dimensions

Readers on

mendeley: 108 Mendeley
citeulike: 1 CiteULike
connotea: 1 Connotea

Summary Patents Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

Hematology News, 07 May 2012

Combination of pegylated IFN-α2b with imatinib increases molecular response rates in patients with low- or intermediate-risk…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.